SCYNEXIS, Inc. Operating Lease, Payments
SCYNEXIS, Inc. (SCYX) reported Operating Lease, Payments of $744.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-03-04
- SCYNEXIS, Inc. operating lease, payments for the quarter ending 2024-12-31 was $185.00K, a 2.21% increase year-over-year.
- SCYNEXIS, Inc. operating lease, payments for the quarter ending 2024-09-30 was $183.00K, a 1.67% increase year-over-year.
- SCYNEXIS, Inc. operating lease, payments for the quarter ending 2024-06-30 was $181.00K, a 2.26% increase year-over-year.
- SCYNEXIS, Inc. operating lease, payments for the quarter ending 2024-03-31 was $181.00K, a 2.26% increase year-over-year.
- SCYNEXIS, Inc. operating lease, payments for fiscal 2025 was $744.00K, a 1.92% increase from fiscal 2024.
- SCYNEXIS, Inc. operating lease, payments for fiscal 2024 was $730.00K, a 2.10% increase from fiscal 2023.
- SCYNEXIS, Inc. operating lease, payments for fiscal 2023 was $715.00K, a 35.67% increase from fiscal 2022.
- SCYNEXIS, Inc. operating lease, payments for fiscal 2022 was $527.00K, a 1.93% increase from fiscal 2021.
| Period end | Operating Lease, Payments 0 month | Operating Lease, Payments | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | $744.00K 10-K · filed 2026-03-04 | |||||
| 2024-12-31 | $185.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $368.00K derived: sum of 2 quarters · filed 2026-03-04 | $549.00K derived: sum of 3 quarters · filed 2026-03-04 | $730.00K 10-K · filed 2026-03-04 | ||
| 2024-09-30 | $183.00K 10-Q · filed 2024-11-06 | $364.00K derived: sum of 2 quarters · filed 2024-11-06 | $545.00K 10-Q · filed 2024-11-06 | $726.00K derived: sum of 4 quarters · filed 2025-03-12 | ||
| 2024-06-30 | $181.00K 10-Q · filed 2024-08-08 | $362.00K 10-Q · filed 2024-08-08 | $543.00K derived: sum of 3 quarters · filed 2025-03-12 | $723.00K derived: sum of 4 quarters · filed 2025-03-12 | ||
| 2024-03-31 | $181.00K 10-Q · filed 2024-05-08 | $362.00K derived: sum of 2 quarters · filed 2025-03-12 | $542.00K derived: sum of 3 quarters · filed 2025-03-12 | $719.00K derived: sum of 4 quarters · filed 2025-03-12 | ||
| 2023-12-31 | $181.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $361.00K derived: sum of 2 quarters · filed 2025-03-12 | $538.00K derived: sum of 3 quarters · filed 2025-03-12 | $715.00K 10-K · filed 2025-03-12 | ||
| 2023-09-30 | $180.00K 10-Q · filed 2024-11-06 | $357.00K derived: sum of 2 quarters · filed 2024-11-06 | $534.00K 10-Q · filed 2024-11-06 | $711.00K derived: sum of 4 quarters · filed 2024-11-06 | ||
| 2023-06-30 | $177.00K 10-Q · filed 2024-08-08 | $355.00K 10-Q · filed 2024-08-08 | $531.00K derived: sum of 3 quarters · filed 2024-08-08 | $649.00K derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | $177.00K 10-Q · filed 2024-05-08 | $354.00K derived: sum of 2 quarters · filed 2024-05-08 | $472.00K derived: sum of 3 quarters · filed 2024-05-08 | $530.00K derived: sum of 4 quarters · filed 2024-05-08 | ||
| 2022-12-31 | $177.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $295.00K derived: sum of 2 quarters · filed 2024-03-28 | $353.00K derived: sum of 3 quarters · filed 2024-03-28 | $527.00K 10-K · filed 2024-03-28 | ||
| 2022-09-30 | $118.00K 10-Q · filed 2023-11-13 | $176.00K derived: sum of 2 quarters · filed 2023-11-13 | $350.00K 10-Q · filed 2023-11-13 | $524.00K derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | $58.00K 10-Q · filed 2023-08-14 | $232.00K 10-Q · filed 2023-08-14 | $406.00K derived: sum of 3 quarters · filed 2023-08-14 | $522.00K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $174.00K 10-Q · filed 2023-05-10 | $348.00K derived: sum of 2 quarters · filed 2023-05-10 | $464.00K derived: sum of 3 quarters · filed 2023-05-10 | $521.00K derived: sum of 4 quarters · filed 2023-05-10 | ||
| 2021-12-31 | $174.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $290.00K derived: sum of 2 quarters · filed 2023-03-31 | $347.00K derived: sum of 3 quarters · filed 2023-03-31 | $517.00K 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $116.00K 10-Q · filed 2022-11-09 | $173.00K derived: sum of 2 quarters · filed 2022-11-09 | $343.00K 10-Q · filed 2022-11-09 | $514.00K derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | $57.00K 10-Q · filed 2022-08-15 | $227.00K 10-Q · filed 2022-08-15 | $398.00K derived: sum of 3 quarters · filed 2022-08-15 | $512.00K derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | $170.00K 10-Q · filed 2022-05-12 | $341.00K derived: sum of 2 quarters · filed 2022-05-12 | $455.00K derived: sum of 3 quarters · filed 2022-05-12 | $511.00K derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $171.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $285.00K derived: sum of 2 quarters · filed 2022-03-29 | $341.00K derived: sum of 3 quarters · filed 2022-03-29 | $507.00K 10-K · filed 2022-03-29 | ||
| 2020-09-30 | $114.00K 10-Q · filed 2021-11-10 | $170.00K derived: sum of 2 quarters · filed 2021-11-10 | $336.00K 10-Q · filed 2021-11-10 | $504.00K derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $56.00K 10-Q · filed 2021-08-16 | $223.00K 10-Q · filed 2021-08-16 | $390.00K derived: sum of 3 quarters · filed 2021-08-16 | $501.00K derived: sum of 4 quarters · filed 2021-08-16 | ||
| 2020-03-31 | $167.00K 10-Q · filed 2021-05-17 | $334.00K derived: sum of 2 quarters · filed 2021-05-17 | $445.00K derived: sum of 3 quarters · filed 2021-05-17 | $500.00K derived: sum of 4 quarters · filed 2021-05-17 | ||
| 2019-12-31 | $167.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $278.00K derived: sum of 2 quarters · filed 2021-03-29 | $333.00K derived: sum of 3 quarters · filed 2021-03-29 | $497.00K 10-K · filed 2021-03-29 | ||
| 2019-09-30 | $111.00K 10-Q · filed 2019-11-12 | $166.00K derived: sum of 2 quarters · filed 2019-11-12 | $330.00K 10-Q · filed 2019-11-12 | |||
| 2019-06-30 | $55.00K 10-Q · filed 2019-08-07 | $219.00K 10-Q · filed 2019-08-07 | ||||
| 2019-03-31 | $164.00K 10-Q · filed 2019-05-08 | |||||
| 2018-03-01 | $7.30M 10-K · filed 2026-03-04 | $7.30M 10-Q · filed 2024-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |